|
|
Volumn 466, Issue 7309, 2010, Pages 909-
|
|
FDA challenges stem-cell clinic
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BONE MARROW;
BONE MARROW TRANSPLANTATION;
CELL CULTURE;
CELL ISOLATION;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG LEGISLATION;
FERTILIZATION IN VITRO;
FOOD AND DRUG ADMINISTRATION;
FRACTURE;
HEALTH CARE COST;
HUMAN;
LEGAL ASPECT;
MEDICAL PRACTICE;
MEDICAL SOCIETY;
MESENCHYMAL STEM CELL;
NOTE;
PATIENT SAFETY;
PHYSICIAN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
STEM CELL TRANSPLANTATION;
SYNOVIAL FLUID;
TENDON INJURY;
ANIMAL;
AUTOTRANSPLANTATION;
LEGISLATION AND JURISPRUDENCE;
REGENERATIVE MEDICINE;
STEM CELL;
UNITED STATES;
ANIMALS;
HUMANS;
REGENERATIVE MEDICINE;
STEM CELL TRANSPLANTATION;
STEM CELLS;
TRANSPLANTATION, AUTOLOGOUS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 77955906240
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/466909a Document Type: Note |
|
Times cited : (27)
|
|
References (0)
|
